methotrexate has been researched along with Forestier-Certonciny Syndrome in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (1.72) | 18.7374 |
1990's | 10 (17.24) | 18.2507 |
2000's | 11 (18.97) | 29.6817 |
2010's | 19 (32.76) | 24.3611 |
2020's | 17 (29.31) | 2.80 |
Authors | Studies |
---|---|
Bolhuis, TE; den Broeder, AA; den Broeder, N; Marsman, DE; van der Maas, A | 1 |
Elliott, L; Pearson, T; Walz, K | 1 |
Darrow, HJ; Raleigh, MF; Stoddard, J | 1 |
Akahoshi, M; Boyadzhieva, Z; Buttgereit, F; Hermann, S; Muche, B; Palmowski, A; Terao, C; Wiebe, E | 1 |
Man-Ger Sun, M; Pope, JE | 1 |
Black, R; Hill, C; Nguyen, L; Proudman, S; Ruediger, C | 1 |
Hellmich, B; Horvath, L | 1 |
Ariani, A; Bortoluzzi, A; Gerli, R; Manara, M; Parisi, S; Prevete, I; Rumi, F; Salvarani, C; Sciré, CA; Sebastiani, GD; Ughi, N | 1 |
Allenbach, Y; Benesova, K; Bingham, CO; Calabrese, LH; Choy, EH; Cope, AP; Finckh, A; Gottenberg, JE; Haanen, JBAG; Jamal, S; Kostine, M; Lambotte, O; Larkin, J; Leipe, J; Marabelle, A; Mariette, X; Radstake, TRDJ; Rusthoven, C; Schaeverbeke, T; Schulze-Koops, H; Thomasen, L; Visser, K; Visser, M | 1 |
de la Torre, ML; Pisoni, CN; Rodríguez, AM | 1 |
Schmidt, WA | 3 |
Mahmood, SB; Nasr, R; Nelson, E; Padniewski, J | 1 |
Buttgereit, F; Dejaco, C; Matteson, EL | 2 |
Hosoda, C; Ishiguro, T; Kanegane, H; Shimizu, Y; Takayanagi, N | 1 |
Lee, YH; Song, GG | 1 |
Bolhuis, T; Broeder, ND; den Broeder, A; Marsman, D; van den Hoogen, F; van der Maas, A | 1 |
Matsushita, S; Taito, S; Yamamoto, N | 1 |
Castañeda, S; González-Gay, MA; Matteson, EL | 1 |
Boers, N; den Broeder, AA; Marsman, DE; van der Maas, A | 1 |
Camellino, D; Dejaco, C | 1 |
De Vita, S; Gregoraci, G; Isola, M; Quartuccio, L | 1 |
Bettili, F; Fracassi, E; Gatti, D; Ghellere, F; Giollo, A; Idolazzi, L; Rossini, M; Viapiana, O | 1 |
Blanco, R; Castañeda, S; García-Castañeda, N; González-Gay, MA; Martínez-Quintanilla, D; Prieto-Peña, D; Vicente, EF | 1 |
Koga, Y; Mori, S | 1 |
Gawroński, K; Kisiel, B; Rzepecki, P; Tłustochowicz, W | 1 |
Seitz, M | 1 |
Buttgereit, F; Dasgupta, B; Dejaco, C; Matteson, EL | 2 |
Füeßl, HS; Stiefelhagen, P | 1 |
Hellmich, B | 1 |
Märker-Hermann, E; Schmidt, WA | 1 |
Agudo, M; Blanco, R; Gonzalez-Gay, MA; Martinez-Dubois, C; Pompei, O | 1 |
Bijlsma, JW; Lems, WF | 1 |
Alba, MA; Flores-Suárez, LF; Mena-Madrazo, JA; Reyes, E | 1 |
Wepner, U | 1 |
Katada, S; Kobayashi, H; Sato, A; Sato, M | 1 |
Caceres, LR; Lichtstein, DM | 1 |
Caporali, R; Cimmino, MA; Ferraccioli, G; Gerli, R; Klersy, C; Montecucco, C; Salvarani, C | 1 |
Stone, JH | 1 |
Cimmino, MA; Garlaschi, G; Parodi, M; Silvestri, E | 1 |
Burmester, GR; Scherer, HU | 1 |
Bennett, RM; Kohli, M | 1 |
Bartoli, E; Casatta, L; De Vita, S; Ferraccioli, G; Salaffi, F | 1 |
Bijlsma, JW; Dinant, HJ; van Albada-Kuipers, GA; van Booma-Frankfort, C; van der Veen, MJ | 1 |
Massarotti, EM | 1 |
Dietzen, CJ; Feinberg, GD; Feinberg, HL; Schrepferman, CG; Sherman, JD | 1 |
Bahlas, S; Davis, P; Ramos-Remus, C | 1 |
Sieper, J | 1 |
Giuliani, MJ; Lacomis, D; Oddis, CV; Wasko, MC | 1 |
Généreau, T | 1 |
Gran, JT | 1 |
Bie, RB; Haugeberg, G; Paulsen, PQ | 1 |
Barilla-LaBarca, ML; Brasington, RD; Lenschow, DJ | 1 |
Krall, PL; Mazanec, DJ; Wilke, WS | 1 |
23 review(s) available for methotrexate and Forestier-Certonciny Syndrome
Article | Year |
---|---|
Alternatives to glucocorticoid monotherapy in the treatment of polymyalgia rheumatica.
Topics: Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica; Systematic Reviews as Topic; Treatment Outcome | 2022 |
Unmet need in the treatment of polymyalgia rheumatica and giant cell arteritis.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica | 2022 |
The Italian Society of Rheumatology clinical practice guidelines for the management of polymyalgia rheumatica.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Clinical Laboratory Techniques; Diagnostic Imaging; Europe; Exercise Therapy; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Italy; Methotrexate; Polymyalgia Rheumatica; Referral and Consultation; Rheumatology; Societies, Medical; Stakeholder Participation | 2020 |
[Inflammatory Muscle Pain: Polymyalgia Rheumatica with or without Large Vessel Vasculitis].
Topics: Aged; Antibodies, Monoclonal, Humanized; Blindness; Diagnosis, Differential; Fatigue; Female; Giant Cell Arteritis; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisolone; Stroke; Ultrasonography; Vasculitis | 2020 |
Polymyalgia rheumatica: An updated review.
Topics: Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Blood Sedimentation; Diagnosis, Differential; Female; Giant Cell Arteritis; Glucocorticoids; Humans; Induction Chemotherapy; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Ultrasonography | 2020 |
Polymyalgia Rheumatica and Giant Cell Arteritis.
Topics: Antibodies, Monoclonal, Humanized; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography | 2020 |
Methotrexate for treating polymyalgia rheumatica: A meta-analysis of randomized controlled trials.
Topics: Antirheumatic Agents; Giant Cell Arteritis; Humans; Methotrexate; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Polymyalgia rheumatica.
Topics: Diagnosis, Differential; Dose-Response Relationship, Drug; Humans; Interleukin-6; Methotrexate; Polymyalgia Rheumatica; Positron-Emission Tomography; Prednisolone; Prognosis; Recurrence | 2017 |
[Polymyalgia rheumatica: new developments and challenges].
Topics: Diagnosis, Differential; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica; Positron Emission Tomography Computed Tomography | 2017 |
Update on treatment of polymyalgia rheumatica.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Clinical Trials as Topic; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica; Treatment Outcome | 2018 |
Treatment of polymyalgia rheumatica.
Topics: Glucocorticoids; Humans; Janus Kinases; Methotrexate; Polymyalgia Rheumatica; Receptors, Interleukin-6 | 2019 |
Glucocorticoid-resistant polymyalgia rheumatica: pretreatment characteristics and tocilizumab therapy.
Topics: Aged; Antibodies, Monoclonal, Humanized; Female; Glucocorticoids; Humans; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisolone; Prednisone; Retreatment; Treatment Outcome | 2016 |
[Polymyalgia rheumatica: What is the current status?].
Topics: Biomarkers; Cytokines; Diagnosis, Differential; Europe; Glucocorticoids; Humans; Immunosuppressive Agents; Interleukin-6; Methotrexate; Polymyalgia Rheumatica; Practice Guidelines as Topic; Rheumatology; United States | 2015 |
Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
Topics: Disease Management; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Shoulder Joint; Temporal Arteries; Ultrasonography | 2016 |
Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
Topics: Antibodies, Monoclonal, Humanized; Diagnostic Imaging; Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Randomized Controlled Trials as Topic | 2016 |
[Diagnostics and treatment of polymyalgia rheumatica].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Autoimmune Diseases; Diagnosis, Differential; Dose-Response Relationship, Drug; Evidence-Based Medicine; Female; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Polymyalgia Rheumatica; Prednisone; Treatment Outcome; Ultrasonography | 2016 |
[Management of polymyalgia rheumatica and large vessel vasculitis].
Topics: Antirheumatic Agents; Biological Products; Combined Modality Therapy; Evidence-Based Medicine; Giant Cell Arteritis; Glucocorticoids; Humans; Immunosuppressive Agents; Methotrexate; Patient Care Management; Polymyalgia Rheumatica; Treatment Outcome | 2016 |
[Polymyalgia rheumatica].
Topics: Adrenal Cortex Hormones; Aged; Diagnosis, Differential; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Methotrexate; Polymyalgia Rheumatica; Tumor Necrosis Factor-alpha | 2009 |
Medical management of polymyalgia rheumatica.
Topics: Age Factors; Antirheumatic Agents; Dose-Response Relationship, Drug; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisone; Risk Factors; Secondary Prevention; Time Factors; Treatment Outcome | 2010 |
[Biologicals in the treatment of rheumatic diseases].
Topics: Abatacept; Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child; Clinical Trials, Phase II as Topic; Cohort Studies; Collagen Diseases; Drug Therapy, Combination; Etanercept; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Immunoconjugates; Immunoglobulin G; Infliximab; Methotrexate; Placebos; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Receptors, Tumor Necrosis Factor; Remission Induction; Rheumatic Diseases; Rituximab; Spondylarthropathies; Spondylitis, Ankylosing; Sulfasalazine; Time Factors; Tumor Necrosis Factor-alpha | 2006 |
Medical aspects of rheumatoid arthritis. Diagnosis and treatment.
Topics: Adrenal Cortex Hormones; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Carpal Tunnel Syndrome; Diagnosis, Differential; Female; Hand; Humans; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Synovial Fluid; Wrist | 1996 |
Current therapy of polymyalgia rheumatica.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Humans; Immunosuppressive Agents; Methotrexate; Pain; Polymyalgia Rheumatica; Pregnenediones | 1999 |
Polymyalgia rheumatica/temporal arteritis: recent advances.
Topics: Adrenal Cortex Hormones; Aged; Azathioprine; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic; Treatment Outcome | 2002 |
4 trial(s) available for methotrexate and Forestier-Certonciny Syndrome
Article | Year |
---|---|
PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial.
Topics: Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Multicenter Studies as Topic; Polymyalgia Rheumatica; Prednisolone; Randomized Controlled Trials as Topic; Treatment Outcome | 2022 |
Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Placebos; Polymyalgia Rheumatica; Prednisone | 2004 |
Methotrexate in polymyalgia rheumatica: preliminary results of an open, randomized study.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Blood Sedimentation; Bone Density; C-Reactive Protein; Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intramuscular; Male; Methotrexate; Osteocalcin; Polymyalgia Rheumatica; Prednisone; Prospective Studies | 1996 |
Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Recurrence | 1996 |
31 other study(ies) available for methotrexate and Forestier-Certonciny Syndrome
Article | Year |
---|---|
Polymyalgia Rheumatica and Giant Cell Arteritis: Rapid Evidence Review.
Topics: C-Reactive Protein; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Myalgia; Polymyalgia Rheumatica; Recurrence | 2022 |
No association between methotrexate and impaired bone mineral density in a cohort of patients with polymyalgia rheumatica, giant cell arteritis, granulomatosis with polyangiitis and other vasculitides-a cross-sectional analysis with dose-response analyses
Topics: Aged; Bone Density; Cohort Studies; Cross-Sectional Studies; Giant Cell Arteritis; Glucocorticoids; Granulomatosis with Polyangiitis; Humans; Methotrexate; Middle Aged; Polymyalgia Rheumatica | 2023 |
Efficacy of methotrexate in polymyalgia rheumatica in routine rheumatology clinical care.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Polymyalgia Rheumatica; Rheumatology | 2020 |
[Treatment of giant cell arteritis and polymyalgia rheumatica].
Topics: Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica | 2020 |
EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors.
Topics: Advisory Committees; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthralgia; Arthritis, Psoriatic; Arthritis, Reactive; Autoantibodies; Decision Making, Shared; Deprescriptions; Europe; Glucocorticoids; Humans; Immune Checkpoint Inhibitors; Immunoglobulins, Intravenous; Immunologic Factors; Medical Oncology; Methotrexate; Myalgia; Myocarditis; Myositis; Neoplasms; Plasma Exchange; Polymyalgia Rheumatica; Rheumatic Diseases; Rheumatology; Severity of Illness Index; Societies, Medical; Tumor Necrosis Factor Inhibitors | 2021 |
Usefulness of Methotrexate in the Reduction of Relapses and Recurrences in Polymyalgia Rheumatica: An Observational Study.
Topics: Antirheumatic Agents; Female; Humans; Longitudinal Studies; Male; Methotrexate; Polymyalgia Rheumatica; Recurrence | 2020 |
Topics: Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Clarithromycin; Ethambutol; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Methotrexate; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nucleic Acid Amplification Techniques; Polymyalgia Rheumatica; Polyps; Prednisolone; Pulmonary Atelectasis; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2020 |
Effect of add-on methotrexate in polymyalgia rheumatica patients flaring on glucocorticoids tapering: a retrospective study.
Topics: Antirheumatic Agents; Case-Control Studies; Female; Glucocorticoids; Humans; Male; Methotrexate; Polymyalgia Rheumatica; Retrospective Studies; Symptom Flare Up; Treatment Outcome | 2021 |
Does methotrexate have no beneficial effect in reducing flares in the treatment of polymyalgia rheumatica patients?
Topics: Drug Administration Schedule; Giant Cell Arteritis; Glucocorticoids; Humans; Methotrexate; Polymyalgia Rheumatica | 2021 |
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients.
Topics: Academic Medical Centers; Administration, Oral; Aged; Antirheumatic Agents; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Male; Methotrexate; Methylprednisolone; Middle Aged; Pain Measurement; Patient Satisfaction; Polymyalgia Rheumatica; Retrospective Studies; Risk Assessment; Severity of Illness Index; Time Factors; Treatment Outcome | 2018 |
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica Is Uncommon but May Be Enhanced by Amino Bisphosphonates.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Bone Density Conservation Agents; Diphosphonates; Electronic Health Records; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methotrexate; Middle Aged; Osteoporosis; Polymyalgia Rheumatica; Prednisone; Retrospective Studies; Treatment Outcome | 2019 |
Polymyalgia rheumatica in a patient with splenic marginal zone lymphoma - a case report.
Topics: Drug Therapy, Combination; Female; Humans; Lymphoma; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Recurrence; Splenectomy; Splenic Neoplasms | 2015 |
[No real alternatives to steroids yet].
Topics: Adrenal Cortex Hormones; Aged; Antibodies, Monoclonal, Humanized; Female; Humans; Male; Methotrexate; Polymyalgia Rheumatica; Prednisolone; Prednisone | 2015 |
[Polymyalgia rheumatic--what's new?].
Topics: Antirheumatic Agents; Humans; Inflammation; Methotrexate; Middle Aged; Polymyalgia Rheumatica | 2016 |
[Polymyalgia rheumatica: new possibilities for treatment, but not diagnosis].
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisone | 2010 |
Giant cell arteritis in Mexican patients.
Topics: Aged; Aged, 80 and over; Amaurosis Fugax; Antirheumatic Agents; Blindness; Ethnicity; Female; Follow-Up Studies; Giant Cell Arteritis; Headache; Humans; Male; Methotrexate; Mexico; Middle Aged; Polymyalgia Rheumatica; Prednisone; Retrospective Studies | 2012 |
[Polymyalgia rheumatica].
Topics: Antirheumatic Agents; Diagnostic Imaging; Female; Glucocorticoids; Humans; Male; Methotrexate; Polymyalgia Rheumatica | 2013 |
[Tormenting muscle pains refractory to all treatment attempts. Finally cortisone therapy leads to right track].
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisolone; Treatment Outcome | 2003 |
[A case of polymyalgia rheumatica with improved steroid-responsibility after discontinuing carbamazepine].
Topics: Aged; Anticonvulsants; Carbamazepine; Drug Resistance; Epilepsy; Female; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisolone; Valproic Acid | 2004 |
Heeding clues to giant cell arteritis. Prompt response can prevent vision loss.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Blindness; Female; Giant Cell Arteritis; Headache; Humans; Methotrexate; Polymyalgia Rheumatica | 2004 |
Summaries for patients. Prednisone plus methotrexate for polymyalgia rheumatica.
Topics: Aged; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Placebos; Polymyalgia Rheumatica; Prednisone | 2004 |
Methotrexate in polymyalgia rheumatica: kernel of truth or curse of Tantalus?
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Drug Therapy, Combination; Humans; Methotrexate; Polymyalgia Rheumatica; Prednisolone | 2004 |
Magnetic resonance imaging in the differential diagnosis between polymyalgia rheumatica and elderly onset rheumatoid arthritis.
Topics: Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Diagnosis, Differential; Diagnostic Errors; Glucocorticoids; Hand; Hand Joints; Humans; Ibuprofen; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Polymyalgia Rheumatica; Prednisolone; Radiography; Treatment Outcome | 2006 |
An association of polymyalgia rheumatica with myelodysplastic syndromes.
Topics: Aged; Blood Cell Count; Bone Marrow; Female; Humans; Methotrexate; Middle Aged; Myelodysplastic Syndromes; Polymyalgia Rheumatica; Prednisone | 1994 |
The use of methotrexate in polymyalgia rheumatica.
Topics: Aged; Aged, 80 and over; Blood Sedimentation; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone; Treatment Outcome | 1996 |
Clinical outcome of 149 patients with polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Polymyalgia Rheumatica; Prednisone | 1998 |
[Basic therapeutics in the management of various forms of arthritis].
Topics: Antimalarials; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Humans; Methotrexate; Polymyalgia Rheumatica; Remission Induction; Spondylitis; Spondylitis, Ankylosing; Sulfasalazine | 1998 |
Giant cell arteritis presenting with proximal weakness and skeletal muscle vasculitis.
Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Methotrexate; Muscle Weakness; Muscle, Skeletal; Polymyalgia Rheumatica; Prednisone; Vasculitis, Leukocytoclastic, Cutaneous | 1999 |
[Horton's disease and rhizomelic pseudopolyarthritis. First International Congress on Horton's Disease and rhizomelic pseudopolyarthritis, Prato (Italy), 25-26 May 1999].
Topics: Adrenal Cortex Hormones; Aged; Antirheumatic Agents; Diagnosis, Differential; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Italy; Methotrexate; Polymyalgia Rheumatica; Randomized Controlled Trials as Topic | 1999 |
Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings.
Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Chlorambucil; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Incidence; Male; Methotrexate; Methylprednisolone; Middle Aged; Norway; Polymyalgia Rheumatica; Prednisolone; Vision Disorders | 2000 |
Methotrexate for corticosteroid-resistant polymyalgia rheumatica and giant cell arteritis.
Topics: Aged; Drug Therapy, Combination; Female; Giant Cell Arteritis; Humans; Male; Methotrexate; Middle Aged; Polymyalgia Rheumatica; Prednisone | 1989 |